Essential targets in therapeutic targeting of cancer metabolism are glycolytic enzymes, including LDHA, PKM2, HK2, ALDOA, G6PD, PPP cycle, glutamine serine metabolism and pyruvate oxidation (Table 1). The gene discussed is ALDOA; the disease is cancer.